UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 445

Sortiert nach

Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties

Pharmaceutical research, 2020-09, Vol.37 (9), p.166-166, Article 166

2020

Volltextzugriff (PDF)

Impact of drug‐drug interactions on phenobarbital pharmacokinetics in pediatric patients

Epilepsia (Copenhagen), 2019-06, Vol.60 (6), p.1266-1267

2019

Volltextzugriff (PDF)

Sufentanil Disposition and Pharmacokinetic Model-Based Dosage Regimen for Sufentanil in Ventilated Full-Term Neonates

Pharmacology, 2021-07, Vol.106 (7-8), p.384-389

2021

Volltextzugriff (PDF)

Vancomycin population pharmacokinetics and dosing proposal for the initial treatment in obese adult patients

Frontiers in pharmacology, 2024-06, Vol.15, p.1364681

2024

Volltextzugriff (PDF)

Evidence for Therapeutic Drug Monitoring of Atypical Antipsychotics

Prague medical report, 2024, Vol.125 (2), p.101-129

2024

Volltextzugriff (PDF)

New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis

Physiological research, 2020, Vol.69 (1), p.1-19

2020

Volltextzugriff (PDF)

Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients

Journal of clinical pharmacy and therapeutics, 2022-09, Vol.47 (9), p.1362-1367

2022

Volltextzugriff (PDF)

Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective

Frontiers in pharmacology, 2023-06, Vol.14, p.1228406-1228406

2023

Volltextzugriff (PDF)

Changes in Rosuvastatin Pharmacokinetics During Postnatal Ontogenesis in Rats

Journal of pharmacy & pharmaceutical sciences, 2021-12, Vol.25, p.1

2021

Volltextzugriff (PDF)

Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in Three Nonadherent Patients

Journal of cardiovascular pharmacology, 2019-02, Vol.73 (2), p.125

2019

Volltextzugriff (PDF)

Effects of Cannabidiol in Inflammation: A Review of Pre-clinical and Clinical Findings

Prague medical report, 2023, Vol.124 (3), p.216-229

2023

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Protein Kinase Inhibitors in the Treatment of Non-small Cell Lung Cancer

Prague medical report, 2023, Vol.124 (3), p.199-215

2023

Volltextzugriff (PDF)

Evaluation of adherence to abiraterone therapy in prostate cancer patients based on a population pharmacokinetic model

British journal of clinical pharmacology, 2024-07

2024

Volltextzugriff (PDF)

Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics

Expert opinion on drug metabolism & toxicology, 2021-03, Vol.17 (3), p.307-321

2021

Volltextzugriff (PDF)

What is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?

Pharmaceutics, 2021-02, Vol.13 (3), p.301

2021

Volltextzugriff (PDF)

Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans

Leukemia, 2023-12, Vol.37 (12), p.2486-2492

2023

Volltextzugriff (PDF)

Factors Affecting Drug Exposure after Inhalation

Prague medical report, 2022-01, Vol.123 (3), p.129-139

2022

Volltextzugriff (PDF)

Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass

Journal of chemotherapy (Florence), 2023-10, Vol.ahead-of-print (ahead-of-print), p.1-9

2023

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Protein Kinase Inhibitors in Breast Cancer Patients

Prague medical report, 2021, Vol.122 (4), p.243-256

2021

Volltextzugriff (PDF)

Explaining dissolution properties of rivaroxaban cocrystals

International journal of pharmaceutics, 2022-06, Vol.622, p.121854-121854, Article 121854

2022

Volltextzugriff (PDF)

Nomogram based on actual body weight for estimation of vancomycin maintenance dose in infants

Infectious diseases (London, England), 2019-05, Vol.51 (5), p.334-339

2019

Volltextzugriff (PDF)

Demonstration of the Rationale for Therapeutic Drug Monitoring of Isavuconazole: A Case Report with a Lung Transplant Recipient

Prague medical report, 2023, Vol.124 (4), p.444-448

2023

Volltextzugriff (PDF)

Initial dosing of intermittent vancomycin in adults: estimation of dosing interval in relation to dose and renal function

European journal of hospital pharmacy. Science and practice, 2021-09, Vol.28 (5), p.276-279

2021

Volltextzugriff (PDF)

Impact of haemolysis on vancomycin disposition in a full-term neonate treated with extracorporeal membrane oxygenation

Perfusion, 2021-11, Vol.36 (8), p.864-867

2021

Volltextzugriff (PDF)

Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections

Antibiotics (Basel), 2022-12, Vol.11 (12), p.1736

2022

Volltextzugriff (PDF)

1 – 25 von 445

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(297)
Mit Volltextzugriff
(408)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties

Impact of drug‐drug interactions on phenobarbital pharmacokinetics in pediatric patients

Sufentanil Disposition and Pharmacokinetic Model-Based Dosage Regimen for Sufentanil in Ventilated Full-Term Neonates

Vancomycin population pharmacokinetics and dosing proposal for the initial treatment in obese adult patients

Evidence for Therapeutic Drug Monitoring of Atypical Antipsychotics

New insights in the mechanisms of impaired redox signaling and its interplay with inflammation and immunity in multiple sclerosis

Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients

Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective

Changes in Rosuvastatin Pharmacokinetics During Postnatal Ontogenesis in Rats

Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in Three Nonadherent Patients

Effects of Cannabidiol in Inflammation: A Review of Pre-clinical and Clinical Findings

Therapeutic Drug Monitoring of Protein Kinase Inhibitors in the Treatment of Non-small Cell Lung Cancer

Evaluation of adherence to abiraterone therapy in prostate cancer patients based on a population pharmacokinetic model

Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics

What is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?

Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans

Factors Affecting Drug Exposure after Inhalation

Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass

Therapeutic Drug Monitoring of Protein Kinase Inhibitors in Breast Cancer Patients

Explaining dissolution properties of rivaroxaban cocrystals

Nomogram based on actual body weight for estimation of vancomycin maintenance dose in infants

Demonstration of the Rationale for Therapeutic Drug Monitoring of Isavuconazole: A Case Report with a Lung Transplant Recipient

Initial dosing of intermittent vancomycin in adults: estimation of dosing interval in relation to dose and renal function

Impact of haemolysis on vancomycin disposition in a full-term neonate treated with extracorporeal membrane oxygenation

Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections

Suchergebnisse filtern